Clear answers before you begin.

Yes. Vela is an online-only clinic focused on medical weight care. Treatment availability depends on provider licensure in your state.

The care experience is online. A provider may still determine that an in-person examination, laboratory testing, urgent evaluation, or care from another clinician is needed.

A licensed provider reviews your information before making any treatment recommendation.

No. Intake starts a clinical evaluation. A provider may recommend a treatment, request more information, suggest a different path, or determine that online treatment is not appropriate.

You can share preferences and questions, but the provider is responsible for determining whether any option is clinically appropriate.

No. Semaglutide acts on GLP-1 receptors. Tirzepatide acts on both GIP and GLP-1 receptors. They also exist in products with different approved uses.

They should not be presented as equivalent to medicines specifically used for chronic weight management. Their roles, evidence, formulations, and risks are different and need separate clinical consideration.

You will see what fees include, whether medication is separate, and any other expected costs before accepting a treatment plan.

Coverage varies by plan and treatment. Any insurance or self-pay details that apply to your care will be explained before you proceed.

If medication is prescribed, dispensing, shipping availability, and expected timing will be explained before treatment begins.

Your patient portal provides one place for intake, care information, and account access.